Trifarotene (Aklief) for the Treatment of Acne
Document Type
Article
Publication Date
10-15-2020
Abstract
Trifarotene (Aklief) is a topical retinoid labeled for the treatment of facial and truncal acne vulgaris in patients nine years and older.1 Similar to other retinoids, its exact mechanism of action is not known, but it may work by normalizing keratinization and by having anti-inflammatory effects through stimulation of retinoic acid receptors.
Publication Title
American Family Physician
Volume
102
Issue
8
First Page
499
Last Page
504
PubMed ID
33064433
Recommended Citation
Osayande, Amimi and McGraw, Candis, "Trifarotene (Aklief) for the Treatment of Acne" (2020). PCOM Scholarly Works. 2092.
https://digitalcommons.pcom.edu/scholarly_papers/2092
Comments
This article was published in American Family Physician, Volume 102, Issue 8, pages 499-504.
The published version is available at https://www.aafp.org/afp/2020/1015/p499.html.
Copyright © 2020 American Academy of Family Physicians.